MAPT and Alzheimer disease: Here, by comparing DS-specific iPSC lines and their isogenic control iPSC lines, we demonstrate that abnormalities in Down syndrome start as early as the iPSC stage and AD-like neuropathological phenotype including abnormal Aß accumulation and Tau pathology progressively manifest themselves in organoids during early development.